Health Condition 1: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx
Conditions
Interventions
Intervention1: Nil: Nil
Sponsors
Dr. Shallu Bansal
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients aged 18 years to 70 years irrespective of gender. 2. Patients who have undergone surgical treatment for head and neck cancer. 3. Patients who are clinically stable and able to understand and respond to the questionnaire. 4. Patients willing to participate in the study and who provide written informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with severe cognitive impairment, psychiatric illness, or neurological disorders that would interfere with reliable questionnaire responses. 2. Patients who are critically ill or medically unstable at the time of data collection. 3. Patients with hearing, speech, or comprehension limitations that preclude meaningful participation, even with assistance. 4. Patients unwilling to participate or unable to provide informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of quality of life scores between the EORTC QLQ-H&N43 questionnaire and the newly developed 11-domain Quality of Life instrument in head and neck cancer patients.Timepoint: at 3month and 6th month postoperatively | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Assessment of construct validity of the novel questionnaire by correlation with EORTC QLQ-H&N43 domain scores 2) Evaluation of internal consistency reliability of the novel questionnaire using Cronbach s alpha 3) Assessment of test retest reliability of the novel questionnaire in clinically stable patients 4) Evaluation of additional domains (financial, psychological, sexual, and spiritual) captured by the novel questionnaire 5) Assessment of feasibility, acceptability, and clarity of both questionnaires using patient rating scale Timepoint: 1) Assessment of construct validity of the novel questionnaire by correlation with EORTC QLQ-H&N43 domain scores Time Point: At 3 and 6 months post-treatment 2) Evaluation of internal consistency reliability of the novel questionnaire using Cronbach s alpha Time Point: At initial assessment (3 months post-treatment) 3) Assessment of test retest reliability of the novel questionnaire in clinically stable patients Time Point: 2 weeks interval after first assessment 4) Evaluation of additional domains (financial, psychological, sexual, and spiritual) captured by the novel questionnaire Time Point: At 3 and 6 months post-treatment 5) Assessment of feasibility, acceptability, and clarity of both questionnaires using patient rating scale Time Point: At the time of questionnaire administration (3 and 6 months) | — |
Countries
India
Contacts
Public ContactDr Ashish Jakhetiya
Geetanjali Dental and Research Institute
Outcome results
None listed